|
| Weekly Top Stories |
Tue, 12 May 2020 |
| We have 24 articles this week. The week’s biggest highlights are : #Alexion Set to Acquire #PortolaPharmaceuticals in $1.41 Billion Deal. Italy’s #MenariniGroup Snaps Up #StemlineTherapeutics for $667 Million. #PTCTherapeutics to Acquire #Censa for $10 Million in Cash, $41 Million in Stock. #AdarePharmaceuticals, Inc. Acquires #OrbisBiosciences. #Medable Lands $25M to Expand Platform for Decentralized Clinical Trials. #Owkin lands $25M for AI-powered research platform. #CoVIg-19PlasmaAlliance: International Organizations Work on Globulin Therapy for COVID-19. |
| Editor's Choice |
|
1.
|
COVID-19 pandemic – Multivalent Vaccines Market Solid Analyzed Segmentation, Demand, Recent Share Estimation and Growth Prospects by Regions to 2025 |
|
2.
|
Impact of COVID-19 Outbreak on Pharmaceutical Lipids Market 2020 : Top Countries Data, Global Analysis, Size, Growth, Defination, Opportunities And 2026 Forecast |
|
3.
|
COVID-19 pandemic – Desloratadine Market Size is Thriving Worldwide- Demand and Analysis 2019-2025 |
|
4.
|
COVID-19 pandemic – Influenza Vaccine Market Challenges and Opportunities 2020-2025 |
|
5.
|
COVID-19 pandemic – Oncology Cytotoxic Drug Market Research Outlook, Recent Trends and Growth Forecast 2020-2025 |
| Top 10 M&A Transactions |
|
6.
|
Alexion Set to Acquire Portola Pharmaceuticals in $1.41 Billion Deal |
|
7.
|
Italy’s Menarini Group Snaps Up Stemline Therapeutics for $667 Million |
|
8.
|
PTC Therapeutics to Acquire Censa for $10 Million in Cash, $41 Million in Stock and More |
|
9.
|
Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies |
|
10.
|
One Step Closer: FTC Clears AbbVie and Allergan’s $63 Billion Merger |
|
11.
|
BioNTech Completes Acquisition of Neon Therapeutics |
|
12.
|
Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences |
|
13.
|
HealthpointCapital Acquires Majority Stake in IlluminOss Medical, Inc. |
|
14.
|
Vaxxel Acquires Transgene’s DuckCelt®-T17 Cell Line to Develop Industrial-scale Vaccines Against Respiratory Viruses |
|
15.
|
North American Partners in Anesthesia (NAPA) Acquires American Anesthesiology From MEDNAX, Inc., to Create One of the Most Comprehensive Anesthesia, Pain Management, and Perioperative Care Companies in the U.S. |
| Top 3 Venture Funding |
|
16.
|
Medable Lands $25M to Expand Platform for Decentralized Clinical Trials |
|
17.
|
Owkin Lands $25M for AI-Powered Research Platform, Braid Health Scores $9m for Teleradiology and More Digital Health Funding |
|
18.
|
Wellth Lands $10M for Behavioral Economic Platform to Improve Health Outcomes |
| Top 4 Partnerships Announcements |
|
19.
|
CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19 |
|
20.
|
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project |
|
21.
|
AAOS and OREF Announce Strategic Partnership |
|
22.
|
BrightInsight, CSL Behring Form Global Digital Health Partnership |
|
Read More Corporate Development and M&A Activity |
|
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
|
|
 |
Editor: Ed Francis
Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.
If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073
Or connect with him at  
|
|
OTHER ADVISORIES
|
Advertise with us
We Reach Half Million Decision Makers in: Healthcare · IT · Retail · IndustrialAdvertise with us and reach the right audience. advertise@distilnfo.com |
Contact Us
 5760 Legacy Dr, B3-405, Plano TX 75024 |
 +1 469-270-3311
|
|
DistilINFO Publications
DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.
You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.
View in browser | Advertise | Contact Us
|
|
|
